The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 213.00
Bid: 211.50
Ask: 213.50
Change: 2.00 (0.95%)
Spread: 2.00 (0.946%)
Open: 207.00
High: 213.50
Low: 207.00
Prev. Close: 211.00
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

16 Apr 2012 14:03

RNS Number : 4159B
Advanced Medical Solutions Grp PLC
16 April 2012
 



For filings with issuer exclude the annex

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ADVANCED MED.SLTN.GP.

 

2. Reason for the notification  (please tick the appropriate box or boxes)

 

An acquisition or disposal of voting rights

X

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify): ___________

 

3. Full name of person(s) subject to the notification obligation:

Ignis Investment Services Limited

 

4. Full name of shareholder(s) (if different from 3.):

 

5. Date of the transaction and date on which the threshold is crossed or reached if different:

13/04/2012

 

6. Date on which issuer notified:

16/04/2012

 

7. Threshold(s) that is/are crossed or reached:

4%

 

 

 

8.Notified details: Nominee holdings

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights viii

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

0453659

6,577,730

3.23%

 

B: Financial Instruments

 

Resulting situation after the triggering transaction xii

 

Type of financial instrument

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

CFD's

 

1,449,690

 

 

0.71%

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration Date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

 

8,027,420.00

3.94%

 

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Vidacos Nominees Ltd (5,765,291.00 2.83%)

State Street Nominees (812,439.00 0.40%)

HSBC (778,690.00 0.38%)

Merrill Lynch (671,000.00 0.33%)

 

 

 

 

 

 

 

Phoenix Group Holdings

Impala Holdings Limited

Ignis Asset management Ltd

Ignis Investment Services Ltd (indirect)

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

Percentage calculation based on Issued Share Capital of 203620367

14. Contact name:

Stuart Caldwell

15. Contact telephone number:

0141 222 8128

 

Note: Annex should only be submitted to the FSA not the issuer

 

Annex: Notification of major interests in shares

A: Identity of the persons or legal entity subject to the notification obligation

Full name (including legal form of legal entities)

Stephanie Griffin

Contact address (registered office for legal entities)

50 Bothwell Street, Glasgow, G2 6HR

Phone number & email

0141 222 8286

Other useful information (at least legal representative for legal persons)

Stephanie Griffin

 

 

B: Identity of the notifier, if applicable

 

Full name

Stuart Caldwell

 

Contact address

50 Bothwell Street, Glasgow, G2 6HR

 

Phone number

0141 222 8128

 

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

Settlements Support Manager

 C: Additional information

 

 

 

For notes on how to complete form TR-1 please see the FSA website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUNVURUKASAAR
Date   Source Headline
31st Oct 20227:00 amRNSLiquiBandFix8® PMA application accepted by FDA
14th Sep 20227:00 amRNSInterim Results
8th Sep 20224:53 pmRNSBlock listing announcement
17th Aug 20227:00 amRNSNotice of Interim Results
1st Aug 20227:00 amRNSDirectorate Change
6th Jul 20227:00 amRNSHalf Year Trading Update
8th Jun 20221:52 pmRNSResults of Annual General Meeting
8th Jun 20227:00 amRNSAnnual General Meeting
31st May 20224:03 pmRNSTotal Voting Rights
25th May 20227:00 amRNSAMS announces US approval for LiquiBand® XL
13th May 20226:08 pmRNSDirector- PDMR Dealing Announcement
29th Apr 20225:43 pmRNSAnnual Report, Notice of AGM and Board Change
21st Apr 20225:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:46 pmRNSDirector/PDMR and PCA Shareholding
16th Mar 20227:00 amRNSUnaudited Preliminary Results
9th Mar 20221:17 pmRNSBlock listing Interim Review
7th Mar 20227:00 amRNSNotice of Results
31st Dec 202112:43 pmRNSTotal Voting Rights
16th Dec 20217:00 amRNSFull Year Trading Update
30th Nov 20214:14 pmRNSTotal Voting Rights
4th Nov 20217:00 amRNSAppointment of Adviser
29th Oct 202111:35 amRNSTotal Voting Rights
11th Oct 20213:35 pmRNSHolding(s) in Company
17th Sep 20211:13 pmRNSBlock listing announcement
15th Sep 20217:00 amRNSInterim Results
17th Aug 20217:00 amRNSNotice of Interim Results
2nd Aug 20217:00 amRNSDirectorate Change
30th Jul 20214:35 pmRNSTotal Voting Rights
30th Jul 20213:51 pmRNSHolding(s) in Company
27th Jul 20217:00 amRNSAppointment of Chief Technology Officer
7th Jul 20217:00 amRNSHalf Year Trading Update
30th Jun 20215:24 pmRNSTotal Voting Rights
8th Jun 20212:24 pmRNSResults of Annual General Meeting
8th Jun 20217:00 amRNSAnnual General Meeting
1st Jun 202110:43 amRNSTotal Voting Rights
14th May 202112:10 pmRNSDirector/PDMR Shareholding
4th May 202110:27 amRNSTotal Voting Rights
30th Apr 20215:30 pmRNSAnnual Report, Notice of AGM and Board Change
21st Apr 20216:19 pmRNSDirector/PDMR Shareholding
20th Apr 20217:00 amRNSSeal-G CE Mark Approval
14th Apr 20216:13 pmRNSDirector/PDMR Shareholding
12th Apr 20213:15 pmRNSHolding(s) in Company
29th Mar 202111:00 amRNSDirector/PDMR Shareholding
17th Mar 20217:00 amRNSUnaudited Preliminary Results
8th Mar 202112:24 pmRNSBlock listing Interim Review
4th Mar 20217:00 amRNSNotice of Results
29th Jan 20214:36 pmRNSTotal Voting Rights
22nd Jan 202111:31 amRNSHolding(s) in Company
12th Jan 20217:00 amRNSDirectorate Change
12th Jan 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.